People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

By combining advanced blood analysis with artificial intelligence, the test is able to identify early signs of Parkinson’s disease in individuals who have not yet shown clinical symptoms ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...